Scottsdale Research Institute (SRI) announced on May 28 [2024] that it will lead the first government-funded study measuring the effects of natural psilocybin mushrooms when treating individuals with life-threatening illnesses. The initiative will proceed after SRI, led by President Sue Sisley, MD, was awarded roughly $2.75 million of a $5 million grant that Arizona leaders…
An annual nationally representative survey on drug use and health reported that 9.68 percent of U.S. adults have used psilocybin at least once in their lifetime, based on data gathered between 2015 and 2018. National Center for Complementary and Integrative Health (NCCIH), which is part of the National Institutes of Health… posted page about psilocybin…
…fentanyl… triggers the activation of the dopamine neurons in the mesolimbic system (also known as the reward system), which includes the ventral tegmental area and the nucleus accubens. The neurons then release a large quantity of dopamine. Normally, dopamine neurons are under the control of inhibitory GABA cells. However, opioids block GABA neurons, which makes…
…the individual level where the psychedelic is consumed sits “atop of a more fundamental collective level, which frames and gives shape” to set-and-setting available… …the results did not find a direct interaction between Lifetime Classic Psychedelic Use (LCPU) and marital status alone…. marital status and family sizes effect on psychedelic returns; to understand how marital…
Here’s another… under-studied prospect of psychedelics: a world without severe chronic pain. And… around the internet or psychedelic conferences, a whole subterranean trove of similar stories opens up. An estimated 51 million Americans suffer from chronic pain – excruciating conditions like migraines, phantom limb pains, or fibromyalgia – and often go without effective treatments. But psychedelics like psilocybin mushrooms and LSD seem to…
Why the VA matters: It’s the largest health system in the country and serves a population with disproportionately high rates of PTSD. The VA announced in January [2024 that it would fund research into psychedelics like MDMA, also known as ecstasy, and psilocybin as potential treatments for post-traumatic stress disorder and depression. While outside groups have…
I want to help understand how to effectively use cannabis and psilocybin as potential tools for pain management. …lethal overdoses from cannabis are almost unheard of. This is remarkable considering that nearly 50 million Americans use it each year… a group of cannabis and pain specialists published a proposed guideline for clinical practice in early 2024 to…
…this will… be the first time in 25 years that the FDA will review a new treatment for PTSD… The FDA is set to decide on the therapy’s fate by the middle of August [2024]… if rescheduled, then lobbying efforts will shift to individual states. Some have policies on the books that will immediately follow…
Earl Bluemenauer, a long-time advocate for marijuana legalization for decades, said he thinks the U.S. policy needs to end the hybridization of state and federal rules of the current system… Blumenauer said he hopes the rule change will lead to enough holdouts reversing course for the Safer Banking Act to pass, which would deschedule marijuana…
…in which a novel topological data analysis (TDA) method is applied to the neurophysiological study of the synergistic effects of meditation and psychedelics. …intriguing evidence of similarities in the phenomenology and neurophysiology of meditation and psychedelics has been found… recent reviews suggest that meditation and psychedelics exhibit similarities and complementary differences, which may indicate potential…
Recent Comments